Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Raze, Retrophin, Alnylam, & More 10/16/14 Boston
Selecta, Sharpening Focus, Gets $20M More to Make Biologics Safer 10/15/14 Boston
East Coast Biotech Roundup: Intarcia, Atlas, Visterra, & More 10/06/14 Boston
The Second Xconomy Boston Healthcare Summit: Request An Invitation 10/02/14 Boston
Oasys Loves That Dirty Water From Fracking and Now, Coal Plants 09/03/14 Boston
Coelacanths And Other IPO Thoughts Before The Autumn Markets Return 08/26/14 National
East Coast Biotech Roundup: Amicus, Accelerator, Seventh Sense, & More 08/15/14 Boston
Novartis Helps Pour $16M Into Seventh Sense for Pain-Free Blood Tests 08/13/14 Boston
T2 Biosystems Sputters Through IPO Queue, Raises $57M 08/07/14 Boston
How a Little Serendipity Led Acceleron to a Crippling Blood Disease 07/17/14 Boston
Seres Makes Push for First Drug, and IPO, of Microbiome Era 07/16/14 Boston
Who Needs Biotech VCs, Anyway? 07/15/14 San Francisco
Stealth Mode is the New Sweet Spot for Some Biotechs 07/14/14 National
One More Thought From Boston 2034: Tech + Biotech + Cleantech = ? 06/17/14 Boston
Moderna, Changing Its Identity, Plots Army of mRNA Spinouts 06/12/14 Boston
East Coast Biotech Roundup: Accelerate LI, ASCO, Akebia, & More 06/09/14 Boston
Microbiome Startup Seres Health Tabs Pharma Vet Pomerantz as CEO 06/02/14 Boston
Get a Window on the Innovation Future at Boston 2034 on June 10 05/07/14 Boston
7 Takeaways From “What’s Hot in Boston Biotech” 04/22/14 Boston
Agios’s Blood Cancer Drug Shines in First Clinical Test 04/06/14 Boston
What’s Hot in Boston Biotech: Here’s the Agenda for April 16 03/27/14 Boston
Concert Pharma Heads to Nasdaq, Prices IPO at $14 Per Share 02/13/14 Boston
Pronutria Lands $12,250,000 Series B Financing Round 02/13/14 Boston
Eleven Prices IPO Below Projected Range, Grabs $50M 02/06/14 Boston
East Coast Biotech Roundup: Scholar Rock, Dicerna, Eleven, & More 01/03/14 Boston
What Was Hyped, and What Fell Out of Favor, This Year in Biotech 12/16/13 National
Novomer Obtains New Financing 12/10/13 Boston
East Coast Biotech Roundup: Juno, Editas, Celgene, & More 12/06/13 Boston
Visterra Adds $8M, Ex-Amag Execs, To Begin Clinical Push for Flu Antibody 12/02/13 Boston
Editas Medicine Obtains $43,000,000 Series A Financing 11/26/13 Boston
Page 2 of 14 « previous page · next page »